Clinical Assessment of All Ceramic Single-retainer Using Upper Canine as Abutment With Minimum Preparation on the Lingual Surface, to Replace the Upper Lateral Incisor and Will be Compared With the All Ceramic Single-retainer Using Upper Central Incisor.

Survival, Prosthesis Clinical Trial

Official title:
Clinical Assessment of Distal Versus Mesial Single-Retainer Resin Bonded Fixed Partial Denture for Replacement of an Upper Lateral Incisor: (Randomized Clinical Trial).

Status Not yet recruiting

Clinical Trial Summary

The Intervention Will be All Ceramic Single-retainer Resin Bonded Fixed Partial Denture Using the Upper Canine as Abutment With Minimum Preparation on the Lingual Surface Within the Enamel Providing Maximum Area for the Retainer Bonding, to Replace the Upper Lateral Incisor and Will be Compared With the Control/Comparator Group Which is the All Ceramic Single-retainer RBFPD Using the Upper Central Incisor. The Participants in This Study Will be Recruited by the Researcher From the Clinic of Fixed Prosthodontics Department, Clinic of Orthodontics Department and Clinic of Diagnosis Department, Cairo University Without Any Financial or Non-financial Incentives.

Clinical Trial Description

The intervention will be all ceramic single-retainer Resin Bonded Fixed Partial Denture using the upper canine as abutment with minimum preparation on the lingual surface within the enamel providing maximum area for the retainer bonding, to replace the upper lateral incisor and will be compared with the control/comparator group which is the all ceramic single-retainer RBFPD using the upper central incisor. This intervention will be done by one investigator in all study groups who has master degree in fixed prosthodontics with eight years of experience. The intervention will be carried out in the clinic of the department of Fixed Prosthodontics, Cairo University under supervision of PhD holder staff members. The self-adhesive dual cure resin cement will be used for cementation in all groups. In the first session, the participant will be informed about all steps from the beginning to the end. All participants will be encouraged to maintain good oral hygiene and attend the regular follow up visits and in case of any complain related to the investigated restoration. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05812066
Study type	Interventional
Source	Cairo University
Contact	mohamed A belead, master
Phone	01124741165
Email	mohamed-belead@dentistry.cu.edu.eg
Status	Not yet recruiting
Phase	N/A
Start date	August 1, 2023
Completion date	February 28, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04618900` - Osteotome-mediated Sinus Floor Elevation With or Without Grafting Material	N/A
Recruiting	`NCT04003558` - Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
Recruiting	`NCT06114030` - Clinical and Radiographical Evaluation of CAD-CAM Crowns With and Without Deep Margin Elevation	N/A
Completed	`NCT05866289` - Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure
Not yet recruiting	`NCT06388395` - Clinical Performance of All-on-4 PEEK and Conventional Prostheses	N/A
Completed	`NCT06242639` - Metal-ceramic Fixed Partial Dentures Fabricated With Laser Sintering
Recruiting	`NCT03595423` - SPAnish Aortic VALVE Multicentric Study
Completed	`NCT03523364` - Survival Rate of All Ceramic Restorations Treated With Air-Water-Blasting Protocol
Recruiting	`NCT05822505` - Monocer AOANJRR Registry-nested Study
Completed	`NCT03239509` - 15 Years Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement Between 50-65 Years
Completed	`NCT04274504` - Osteopontin in Metastatic Breast Cancer Patients
Completed	`NCT04749953` - Maxillary Sinus Floor Augmentation With Different Grafting Materials	N/A
Completed	`NCT03510065` - Prevision® PMCF Study
Recruiting	`NCT05818891` - Multicenter Mpact DM France

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.